Skip to main content
. 2022 Jan 11;45(3):585–593. doi: 10.2337/dc21-1883

Figure 1.

Figure 1

Cumulative incidence of CVD (P = 0.8393) (A), MACE (P = 0.1408) (B), and reduced eGFR (P = 0.0023) (C) during EDIC, separately by overall DCCT early rapid eGFR loss (i.e., ≥3% vs. <3% annual loss).